Submit Deal

FLERIE INVEST

HQ - Stockholm

Summary

Listed Swedish life‑science investor focusing on long‑term investments in private companies

Deals Overview

Total Deals6

Valued Deals5

Total Value£ 345 M

Avg. Deal Size£ 69 M

Market Context

Senior Management

Ted Fjällman
CEO
Cecilia Schéele
CFO
Carl-Johan Spak
Senior Advisor

Sort

15 Oct 2021|Sweden|Pharmaceuticals

Target: COBRA BIOLOGICS MATFORS

Bidder: FLERIE INVEST

4 Service Providers

1 Target | 1 Bidder | 2 Vendor

6 Dealmakers

1 Target | 2 Bidder | 3 Vendor

£ 37 M

Value

18 Aug 2021|Iceland|Biotechnology

Target: EPIENDO PHARMACEUTICALS

Bidder: EUROPEAN INNOVATION COUNCIL FUND

6 Service Providers

1 Target | 5 Bidder

21 Dealmakers

1 Target | 20 Bidder

£ 16 M

Value

07 Mar 2022|United Kingdom|Biotechnology

Target: MICROBIOTICA

Bidder: FLERIE INVEST

8 Service Providers

2 Target | 6 Bidder

11 Dealmakers

5 Target | 6 Bidder

£ 50 M

Value

16 Oct 2023|Germany|Biotechnology

Target: CORIOLIS PHARMA

Bidder: FRONTIER BIOSOLUTIONS

5 Service Providers

1 Target | 4 Bidder

8 Dealmakers

2 Target | 6 Bidder

n/a

Value

20 May 2024|Sweden|Pharmaceuticals

Target: FLERIE INVEST

Bidder: INDEX PHARMACEUTICALS

7 Service Providers

4 Target | 3 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 225 M

Value

09 Jan 2025|Sweden|Biotechnology

Target: ANACARDIO

Bidder: NOVO HOLDINGS A/S

4 Service Providers

1 Target | 3 Bidder

6 Dealmakers

2 Target | 4 Bidder

£ 14 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy